Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Kennen MacKay's Stock Ratings
RBC Capital Analyst
Kennen MacKay is an analyst at RBC Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/23/2025
Overall Average Return
7.43%
Smart Score
Overall Average Return Percentile
60th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/17/2024 | NUVB | Buy Now | Nuvation Bio | $2.08 | 139.81% | Kennen MacKay56% | $4 → $5 | Maintains | Outperform | Get Alert |
| 06/27/2023 | AGIO | Buy Now | Agios Pharmaceuticals | $28.43 | 47.71% | Kennen MacKay56% | $40 → $42 | Maintains | Outperform | Get Alert |
| 08/05/2022 | AMGN | Buy Now | Amgen | $277.61 | -14.99% | Kennen MacKay56% | $224 → $236 | Maintains | Sector Perform | Get Alert |
| 03/21/2022 | IMGN | Buy Now | Immunogen | — | — | Kennen MacKay56% | $9 → $6 | Downgrade | Outperform → Sector Perform | Get Alert |
| 02/25/2022 | AGIO | Buy Now | Agios Pharmaceuticals | $28.43 | 135.63% | Kennen MacKay56% | $61 → $67 | Maintains | Outperform | Get Alert |
| 12/21/2021 | AMGN | Buy Now | Amgen | $277.61 | -21.47% | Kennen MacKay56% | $216 → $218 | Maintains | Sector Perform | Get Alert |
| 12/14/2021 | ARNA | Buy Now | Arena Pharmaceuticals | — | — | Kennen MacKay56% | $76 → $100 | Downgrade | Outperform → Sector Perform | Get Alert |
| 11/03/2021 | EXEL | Buy Now | Exelixis | $36.70 | -15.53% | Kennen MacKay56% | $32 → $31 | Maintains | Outperform | Get Alert |
| 11/03/2021 | AMGN | Buy Now | Amgen | $277.61 | -22.19% | Kennen MacKay56% | $217 → $216 | Maintains | Sector Perform | Get Alert |
| 11/03/2021 | ADCT | Buy Now | ADC Therapeutics | $1.29 | 2535.66% | Kennen MacKay56% | $33 → $34 | Maintains | Outperform | Get Alert |
| 10/12/2021 | ATNX | Buy Now | Athenex | — | — | Kennen MacKay56% | $160 → $100 | Maintains | Outperform | Get Alert |
| 10/12/2021 | LIFE | Buy Now | aTyr Pharma | — | — | Kennen MacKay56% | → $22 | Initiates | → Outperform | Get Alert |
| 09/30/2021 | PRTA | Buy Now | Prothena Corp | $9.61 | 753.72% | Kennen MacKay56% | $59 → $82 | Maintains | Outperform | Get Alert |
| 09/27/2021 | SGEN | Buy Now | Seagen | — | — | Kennen MacKay56% | $148 → $154 | Maintains | Sector Perform | Get Alert |
| 09/27/2021 | XLRN | Buy Now | Acceleron Pharma | — | — | Kennen MacKay56% | $113 → $179 | Maintains | Sector Perform | Get Alert |
| 08/09/2021 | ADCT | Buy Now | ADC Therapeutics | $1.29 | 2458.14% | Kennen MacKay56% | → $33 | Initiates | → Outperform | Get Alert |
| 08/06/2021 | PBYI | Buy Now | Puma Biotechnology | $3.05 | 96.72% | Kennen MacKay56% | $13 → $6 | Maintains | Sector Perform | Get Alert |
| 08/06/2021 | ATNX | Buy Now | Athenex | — | — | Kennen MacKay56% | $180 → $160 | Maintains | Outperform | Get Alert |
| 07/29/2021 | BMRN | Buy Now | Biomarin Pharmaceutical | $61.79 | 42.42% | Kennen MacKay56% | $87 → $88 | Maintains | Sector Perform | Get Alert |
| 07/19/2021 | PRTA | Buy Now | Prothena Corp | $9.61 | 514.26% | Kennen MacKay56% | $50 → $59 | Maintains | Outperform | Get Alert |
| 06/11/2021 | PRTA | Buy Now | Prothena Corp | $9.61 | 420.56% | Kennen MacKay56% | $28 → $50 | Maintains | Outperform | Get Alert |
| 04/30/2021 | NRIX | Buy Now | Nurix Therapeutics | $11.64 | 260.67% | Kennen MacKay56% | → $42 | Initiates | → Outperform | Get Alert |
| 04/28/2021 | AMGN | Buy Now | Amgen | $277.61 | -21.83% | Kennen MacKay56% | $220 → $217 | Maintains | Sector Perform | Get Alert |
| 02/16/2021 | SGEN | Buy Now | Seagen | — | — | Kennen MacKay56% | $186 → $169 | Maintains | Sector Perform | Get Alert |
| 02/01/2021 | SGEN | Buy Now | Seagen | — | — | Kennen MacKay56% | $188 → $186 | Downgrade | Outperform → Sector Perform | Get Alert |
| 10/22/2020 | MESO | Buy Now | Mesoblast | $11.13 | 7.79% | Kennen MacKay56% | → $48 | Initiates | → Sector Perform | Get Alert |
| 09/15/2020 | SGEN | Buy Now | Seagen | — | — | Kennen MacKay56% | $175 → $191 | Maintains | Outperform | Get Alert |
| 08/20/2020 | BMRN | Buy Now | Biomarin Pharmaceutical | $61.79 | 48.89% | Kennen MacKay56% | $123 → $92 | Downgrade | Outperform → Sector Perform | Get Alert |
| 05/08/2020 | ABEO | Buy Now | Abeona Therapeutics | $5.20 | 34.62% | Kennen MacKay56% | $275 → $175 | Maintains | Outperform | Get Alert |
| 05/01/2020 | SGEN | Buy Now | Seagen | — | — | Kennen MacKay56% | $148 → $149 | Maintains | Outperform | Get Alert |
| 04/20/2020 | SGEN | Buy Now | Seagen | — | — | Kennen MacKay56% | $121 → $147 | Maintains | Outperform | Get Alert |
| 03/18/2020 | ABEO | Buy Now | Abeona Therapeutics | $5.20 | 111.54% | Kennen MacKay56% | $350 → $275 | Maintains | Outperform | Get Alert |
| 01/31/2020 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Kennen MacKay56% | → $135 | Reinstates | → Outperform | Get Alert |
| 01/24/2020 | BMRN | Buy Now | Biomarin Pharmaceutical | $61.79 | — | Kennen MacKay56% | — | Upgrade | Sector Perform → Sector Outperform | Get Alert |
| 11/08/2019 | OBSV | Buy Now | ObsEva | — | — | Kennen MacKay56% | $16 → $4 | Downgrade | Outperform → Neutral | Get Alert |
| 10/11/2019 | RARX | Buy Now | Ra Pharmaceuticals | — | — | Kennen MacKay56% | — | Downgrade | Outperform → Sector Perform | Get Alert |
| 04/03/2019 | MRUS | Buy Now | Merus | $41.98 | -45.21% | Kennen MacKay56% | $18 → $23 | Upgrade | Sector Perform → Outperform | Get Alert |
| 07/19/2018 | OBSV | Buy Now | ObsEva | — | — | Kennen MacKay56% | → $24 | Initiates | → Outperform | Get Alert |
| 04/23/2018 | PRTA | Buy Now | Prothena Corp | $9.61 | — | Kennen MacKay56% | — | Downgrade | Outperform → Sector Perform | Get Alert |
| 04/04/2018 | ANAB | Buy Now | AnaptysBio | $20.48 | — | Kennen MacKay56% | — | Downgrade | Outperform → Sector Perform | Get Alert |
| 02/27/2018 | OBSV | Buy Now | ObsEva | — | — | Kennen MacKay56% | $16 → $18 | Maintains | Outperform | Get Alert |
| 01/02/2018 | MRUS | Buy Now | Merus | $41.98 | — | Kennen MacKay56% | — | Downgrade | Outperform → Sector Perform | Get Alert |
| 09/15/2017 | BIVV | Buy Now | Bioverativ | — | — | Kennen MacKay56% | → $59 | Initiates | → Sector Perform | Get Alert |
| 09/15/2017 | BMRN | Buy Now | Biomarin Pharmaceutical | $61.79 | 50.51% | Kennen MacKay56% | → $93 | Initiates | → Sector Perform | Get Alert |
| 09/15/2017 | XLRN | Buy Now | Acceleron Pharma | — | — | Kennen MacKay56% | → $44 | Initiates | → Sector Perform | Get Alert |
| 09/15/2017 | RARX | Buy Now | Ra Pharmaceuticals | — | — | Kennen MacKay56% | → $21 | Initiates | → Outperform | Get Alert |
| 09/15/2017 | PRTA | Buy Now | Prothena Corp | $9.61 | 805.78% | Kennen MacKay56% | → $87 | Initiates | → Outperform | Get Alert |
| 09/15/2017 | MRUS | Buy Now | Merus | $41.98 | -33.3% | Kennen MacKay56% | → $28 | Initiates | → Outperform | Get Alert |
| 09/15/2017 | KPTI | Buy Now | Karyopharm Therapeutics | $6.27 | 123.29% | Kennen MacKay56% | → $210 | Initiates | → Outperform | Get Alert |
| 09/15/2017 | FPRX | Buy Now | Five Prime Therapeutics | — | — | Kennen MacKay56% | → $41 | Initiates | → Outperform | Get Alert |
| 09/15/2017 | EXEL | Buy Now | Exelixis | $36.70 | -12.81% | Kennen MacKay56% | → $32 | Initiates | → Outperform | Get Alert |
| 09/15/2017 | ATNX | Buy Now | Athenex | — | — | Kennen MacKay56% | → $700 | Initiates | → Outperform | Get Alert |
| 09/15/2017 | ANAB | Buy Now | AnaptysBio | $20.48 | 95.31% | Kennen MacKay56% | → $40 | Initiates | → Outperform | Get Alert |
| 09/15/2017 | AGIO | Buy Now | Agios Pharmaceuticals | $28.43 | 174.31% | Kennen MacKay56% | → $78 | Initiates | → Outperform | Get Alert |
| 02/21/2017 | OBSV | Buy Now | ObsEva | — | — | Kennen MacKay56% | — | Initiates | → Outperform | Get Alert |
| 02/21/2017 | ANAB | Buy Now | AnaptysBio | $20.48 | 66.02% | Kennen MacKay56% | → $34 | Initiates | → Outperform | Get Alert |
| 01/23/2017 | BMRN | Buy Now | Biomarin Pharmaceutical | $61.79 | 73.17% | Kennen MacKay56% | $111 → $107 | Assumes | Outperform → Outperform | Get Alert |
| 12/12/2016 | SGEN | Buy Now | Seagen | — | — | Kennen MacKay56% | $53 → $70 | Downgrade | Outperform → Neutral | Get Alert |
| 03/29/2016 | PBYI | Buy Now | Puma Biotechnology | $3.05 | 1080.33% | Kennen MacKay56% | $103 → $36 | Downgrade | Outperform → Sector Perform | Get Alert |
| 03/22/2016 | BMRN | Buy Now | Biomarin Pharmaceutical | $61.79 | 76.4% | Kennen MacKay56% | $114 → $109 | Maintains | Outperform | Get Alert |
| 03/03/2016 | BMRN | Buy Now | Biomarin Pharmaceutical | $61.79 | 84.5% | Kennen MacKay56% | $110 → $114 | Maintains | Outperform | Get Alert |
| 02/26/2016 | BMRN | Buy Now | Biomarin Pharmaceutical | $61.79 | 102.3% | Kennen MacKay56% | $155 → $125 | Maintains | Outperform | Get Alert |
| 01/20/2016 | SGEN | Buy Now | Seagen | — | — | Kennen MacKay56% | → $52 | Initiates | → Outperform | Get Alert |
| 06/18/2015 | BMRN | Buy Now | Biomarin Pharmaceutical | $61.79 | 134.67% | Kennen MacKay56% | $125 → $145 | Maintains | Outperform | Get Alert |
| 05/06/2015 | SGEN | Buy Now | Seagen | — | — | Kennen MacKay56% | → $51 | Assumes | → Outperform | Get Alert |
| 11/12/2012 | SGEN | Buy Now | Seagen | — | — | Kennen MacKay56% | → $28 | Initiates | → Outperform | Get Alert |
